A meta-analysis attempts to clear the uncertainty around this tomato-based nutrient.
Updating the story for lycopene and blood pressure, Chinese researchers have completed the latest meta-analysis on this tomato compound and its blood pressure effects.
Writing in the journal Nutrients, they compiled the results of six studies that met inclusion criteria-studies ranged from 4 to 16 weeks in duration, using 4.5 to 15 mg of daily lycopene with healthy or hypertensive participants.
Considering all of the available data, lycopene use significantly lowered systolic blood pressure-but not diastolic blood pressure-and effects were most prominent in Asians and subjects who already had high blood pressure to begin with. A dosage of at least 12 mg yielded the best results.
Manufacturers likely prefer natural ingredients that can lower both dystolic and diastolic blood pressure, but, considering the side effects associated with hypertensive drugs and the limited availability of natural alternatives, lycopene may still be useful.
It’s worth noting that four of the six studies used Lyc-O-Mato lycopene from Lycored Ltd. (Beer Sheva, Israel).
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.